NCT02336854View on ClinicalTrials.gov

Tacrobell tab_Phase1_PK

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 12, 2015

Primary Completion Date

February 2, 2015

Study Completion Date

March 19, 2015

Conditions
Immunosuppressant(Organ Transplantation, RA)
Interventions
DRUG

Tacrobell tab. 2mg

DRUG

Prograf cap. 2mg

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY